Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Takakura

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Plos One|September 10, 2016
MicroRNA Gene Expression Signature Driven by miR-9 Overexpression in Ovarian Clear Cell CarcinomaNozomu Yanaihara, Yukiko Noguchi, Misato Saito, et al.
International Journal of Clinical Oncology|April 20, 2006
Nonpuerperal inversion of the uterus associated with endometrial cancer: a case reportKazu Ueda, Aikou Okamoto, Kyosuke Yamada, et al.
Gynecologic Oncology Reports|May 27, 2026
Durable complete remission of pulmonary metastases with bevacizumab plus olaparib maintenance therapy in homologous recombination-deficient gynecologic large-cell neuroendocrine carcinoma: A case reportYasushi Iida, Yoko Saito, Miwako Shimazaki, et al.
Oncology Reports|February 12, 2005
Genes associated with the genesis of leiomyoma of the uterus in a commonly deleted chromosomal region at 7q22Emi Saito, Aikou Okamoto, Misato Saito, et al.
Oncology Reports|July 14, 2005
Clinical significance of p21(WAF1/CIP1) and p53 expression in serous cystadenocarcinoma of the ovaryFumitoshi Terauchi, Aikou Okamoto, Takeo Nagashima, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 23, 2010
Randomized phase II trial of paclitaxel plus carboplatin therapy versus irinotecan plus cisplatin therapy as first-line chemotherapy for clear cell adenocarcinoma of the ovary: a JGOG studySatoshi Takakura, Masashi Takano, Fumiaki Takahashi, et al.
Molecular Carcinogenesis|April 10, 2015
Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovaryNozomu Yanaihara, Yukihiro Hirata, Noriko Yamaguchi, et al.
The Journal of Obstetrics and Gynaecology Research|August 29, 2023
Comparison of the risk of ovarian malignancy algorithm and Copenhagen Index for the preoperative assessment of Japanese women with ovarian tumorsMakoto Iizuka, Yoshinobu Hamada, Jun Matsushima, et al.
Oncology Reports|April 11, 2009
Mesenchymal to epithelial transition in the human ovarian surface epithelium focusing on inclusion cystsSanshiro Okamoto, Aikou Okamoto, Takashi Nikaido, et al.
International Journal of Oncology|April 6, 2005
FGF7-like gene is associated with pericentric inversion of chromosome 9, and FGF7 is involved in the development of ovarian cancerTakaomi Yasuhara, Aikou Okamoto, Takanori Kitagawa, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Plos One|September 10, 2016
MicroRNA Gene Expression Signature Driven by miR-9 Overexpression in Ovarian Clear Cell CarcinomaNozomu Yanaihara, Yukiko Noguchi, Misato Saito, et al.
International Journal of Clinical Oncology|April 20, 2006
Nonpuerperal inversion of the uterus associated with endometrial cancer: a case reportKazu Ueda, Aikou Okamoto, Kyosuke Yamada, et al.
Gynecologic Oncology Reports|May 27, 2026
Durable complete remission of pulmonary metastases with bevacizumab plus olaparib maintenance therapy in homologous recombination-deficient gynecologic large-cell neuroendocrine carcinoma: A case reportYasushi Iida, Yoko Saito, Miwako Shimazaki, et al.
Oncology Reports|February 12, 2005
Genes associated with the genesis of leiomyoma of the uterus in a commonly deleted chromosomal region at 7q22Emi Saito, Aikou Okamoto, Misato Saito, et al.
Oncology Reports|July 14, 2005
Clinical significance of p21(WAF1/CIP1) and p53 expression in serous cystadenocarcinoma of the ovaryFumitoshi Terauchi, Aikou Okamoto, Takeo Nagashima, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 23, 2010
Randomized phase II trial of paclitaxel plus carboplatin therapy versus irinotecan plus cisplatin therapy as first-line chemotherapy for clear cell adenocarcinoma of the ovary: a JGOG studySatoshi Takakura, Masashi Takano, Fumiaki Takahashi, et al.
Molecular Carcinogenesis|April 10, 2015
Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovaryNozomu Yanaihara, Yukihiro Hirata, Noriko Yamaguchi, et al.
The Journal of Obstetrics and Gynaecology Research|August 29, 2023
Comparison of the risk of ovarian malignancy algorithm and Copenhagen Index for the preoperative assessment of Japanese women with ovarian tumorsMakoto Iizuka, Yoshinobu Hamada, Jun Matsushima, et al.
Oncology Reports|April 11, 2009
Mesenchymal to epithelial transition in the human ovarian surface epithelium focusing on inclusion cystsSanshiro Okamoto, Aikou Okamoto, Takashi Nikaido, et al.
International Journal of Oncology|April 6, 2005
FGF7-like gene is associated with pericentric inversion of chromosome 9, and FGF7 is involved in the development of ovarian cancerTakaomi Yasuhara, Aikou Okamoto, Takanori Kitagawa, et al.
Pageof 4